|
"shao yu yang"的相關文件
顯示項目 61-70 / 106 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2019 |
Plasma Aldosterone after Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes after Adrenalectomy for Primary Aldosteronism
|
Wu C.-H.;Wu V.;Yang Y.-W.;Lin Y.-H.;Shao-Yu Yang;Lin P.-C.;Chang C.-C.;Tsai Y.-C.;Wang S.-M.; Wu C.-H.; Wu V.; Yang Y.-W.; Lin Y.-H.; SHAO-YU YANG; Lin P.-C.; Chang C.-C.; Tsai Y.-C.; Wang S.-M. |
| 臺大學術典藏 |
2018-09-10T18:05:09Z |
Update of pathophysiology and management of diabetic kidney disease
|
Lin, Y.-C. and Chang, Y.-H. and Yang, S.-Y. and Wu, K.-D. and Chu, T.-S.; SHAO-YU YANG |
| 臺大學術典藏 |
2018-09-10T18:05:09Z |
�C�ʵ�Ŧ�f�f�H���ͯ����ɥR
|
SHAO-YU YANG; ���� |
| 臺大學術典藏 |
2018-09-10T18:05:05Z |
Frail phenotype is associated with distinct quantitative electroencephalographic findings among end-stage renal disease patients: An observational study
|
Chao, C.-T. and Lai, H.-J. and Tsai, H.-B. and Yang, S.-Y. and Huang, J.-W.; HUNG-BIN TSAI; CHIA-TER CHAO; JENQ-WEN HUANG; SHAO-YU YANG |
| 臺大學術典藏 |
2018-09-10T18:04:13Z |
The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: A hypothesis generating pilot study
|
Wu, V.-C. and Wu, C.-H. and Yang, Y.-W. and Huang, K.-H. and Chang, C.-H. and Yang, S.-Y. and Lin, Y.-H. and Wu, K.-D.; VIN-CENT WU; SHAO-YU YANG; YA-WEN YANG |
| 臺大學術典藏 |
2018-09-10T18:01:07Z |
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
|
SHUO-MENG WANG; SHAO-YU YANG; Wu, V.-C. and Wang, S.-M. and Chueh, S.-C.J. and Yang, S.-Y. and Huang, K.-H. and Lin, Y.-H. and Wang, J.-J. and Connolly, R. and Hu, Y.-H. and Gomez-Sanchez, C.E. and Peng, K.-Y. and Wu, K.-D.; VIN-CENT WU; YEN-HUNG LIN |
| 臺大學術典藏 |
2018-09-10T15:38:17Z |
A low-salt diet increases the expression of renal sirtuin 1 through activation of the ghrelin receptor in rats
|
Yang, Shao-Yu;Lin, Shuei-Liong;Chen, Yung-Ming;Wu, Vin-Cent;Yang, Wei-Shiung;Wu, Kwan-Dun; Yang, S.-Y., Lin, S.-L., Chen, Y.-M., Wu, V.-C., Yang, W.-S., Wu, K.-D.; 陳永銘;楊紹佑;楊偉勛;吳允升;吳寬墩;林水龍; Yang, Shao-Yu; VIN-CENT WU; Lin, Shuei-Liong; SHUEI-LIONG LIN; Hsieh, Chia-Hung; Chen, Yung-Ming; WEI-SHIUNG YANG; SHAO-YU YANG; Wu, Vin-Cent; YUNG-MING CHEN; Yang, Wei-Shiung; Wu, Kwan-Dun |
| 臺大學術典藏 |
2018-09-10T15:38:17Z |
Relative Thrombocytosis Predicts Poor Outcomes in Patients with Advanced Chronic Kidney Disease
|
Ping-Min Chen;Ping-Yu Chen;Chun-Fu Lai;Shao-Yu Yang;Vin-Cent Wu;Tze-Wah Kao;Jenq-Wen Huang;Wen-Chih Chiang;Chih-Kang Chiang;Shuei-Liong Lin;Yung-Ming Chen;Tzong-Shinn Chu;Ming-Shiou Wu;Kwan-Dun Wu;Tun-Jun Tsai;Kuan-Yu Hung; VIN-CENT WU; SHUEI-LIONG LIN |
| 臺大學術典藏 |
2018-09-10T15:38:11Z |
Benefits and limitations of incretin-based therapies and sodium-glucose transporter 2 inhibitors on diabetic kidney disease
|
Lin, Y.-C. and Yang, S.-Y.; SHAO-YU YANG |
| 臺大學術典藏 |
2018-09-10T15:33:43Z |
Downregulation of angiotensin type 1 receptor and nuclear factor-κ B by sirtuin 1 contributes to renoprotection in unilateral ureteral obstruction
|
Wang, Jann-Yuan; Yang, Wei-Shiung; YUNG-MING CHEN; Wu, Kwan-Dun; Yu, Chong-Jen; Lee, Li-Na; 李麗娜; 許嘉林; 余忠仁; 樹金忠; 王振源; Wu, Vin-Cent; Yang, Shao-Yu;Lin, Shuei-Liong;Chen, Yung-Ming;Wu, Vin-Cent;Yang, Wei-Shiung;Wu, Kwan-Dun; Yang, S.-Y. and Lin, S.-L. and Chen, Y.-M. and Wu, V.-C. and Yang, W.-S. and Wu, K.-D.; 陳永銘;楊紹佑;楊偉勛;吳允升;吳寬墩;林水龍; Lin, Chou-Han; VIN-CENT WU; Yang, Shao-Yu; Shu, Chin-Chung; Lin, Shuei-Liong; SHUEI-LIONG LIN; WEI-SHIUNG YANG; Hsu, Chia-Lin; Chen, Yung-Ming; Cheng, Shih-Lung; SHAO-YU YANG |
顯示項目 61-70 / 106 (共11頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目
|
